Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,639,404,964
-$732,715,152 QoQ
Shares Held
43,886,420
-17.2% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#10
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. MRK ranks #4 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,639,404,964 | 43,886,420 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $6,372,120,116 | 52,972,983 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $3,073,589,674 | 29,199,978 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $2,954,474,221 | 35,201,647 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $2,519,011,460 | 31,821,772 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $2,558,897,996 | 28,508,222 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $2,696,888,364 | 27,109,855 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $3,098,582,817 | 27,285,865 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $3,477,167,867 | 28,086,978 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $3,517,907,988 | 26,660,917 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $2,823,238,381 | 25,896,518 | Shares | Sole | 2024-12-26 | |
| 2023-09-30 | $2,363,094,420 | 22,953,807 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,776,666,025 | 24,063,316 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $2,097,220,527 | 19,712,572 | Shares | Other | 2023-05-18 | |
| 2022-12-31 | $2,640,090,747 | 23,795,341 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $2,022,952,247 | 23,489,924 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,072,280,412 | 22,729,850 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $1,564,006,157 | 19,061,623 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $1,393,340,637 | 18,180,332 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $1,297,069,625 | 17,268,934 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $1,632,165,124 | 20,987,079 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $1,937,905,723 | 25,138,211 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $2,137,429,512 | 26,129,957 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $2,359,526,109 | 28,445,148 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,108,853,805 | 27,270,825 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $2,379,166,919 | 30,922,380 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||